Venous Thromboembolism
📧 Sign up to get email alerts when something new happens for Venous Thromboembolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-10-10Clinical Trial Update: Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery [Phase 2]
Pfizer completed a Phase 2 trial evaluating PD 0348292 for preventing venous thromboembolism (deep vein thrombosis and pulmonary embolism) a…
-
CLINICAL_TRIALS trial_result · 2007-04-27Clinical Trial Update: Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients [Phase 3]
Phase 3 trial evaluating dalteparin for primary prophylaxis of venous thromboembolism in brain tumor patients has completed; no results are …
-
CLINICAL_TRIALS trial_result · 2007-02-21Clinical Trial Update: Thromboprophylaxis in Critically Ill Patients [Phase 4]
A Phase 4 clinical trial evaluating thromboprophylaxis in critically ill patients for venous thromboembolism was terminated.
-
CLINICAL_TRIALS trial_result · 2007-02-09Clinical Trial Update: Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study) [Phase 4]
The Main LITE study comparing low-molecular-weight heparin to warfarin for long-term treatment of proximal deep vein thrombosis has complete…
-
CLINICAL_TRIALS trial_result · 2007-02-09Clinical Trial Update: Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin [Phase 4]
A Phase 4 trial comparing long-term out-of-hospital treatment of proximal deep vein thrombosis with low-molecular-weight heparin alone versu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2006-11-17Clinical Trial Update: PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot) [Phase 3]
Phase 3 PROTECT Pilot trial update on prophylaxis for thromboembolism in critically ill patients; the trial status is completed.